Commentary on the clinical and preclinical dosage limits of interstitially administered magnetic fluids for therapeutic hyperthermia based on current practice and efficacy models

Author(s): Paul Southern, Quentin A. Pankhurst

Published in: International Journal of Hyperthermia, Issue 34/6, 2017, Page(s) 671-686, ISSN 0265-6736

DOI: 10.1080/02656736.2017.1365953


How gastrin-releasing peptide receptor (GRPR) and αvβ3 integrin expression reflect reorganization features of tumors after hyperthermia treatments

Author(s): Sandra Hallasch, Sindy Frick, Maximilian Jung, Ingrid Hilger

Published in: Scientific Reports, Issue 7/1, 2017, ISSN 2045-2322

DOI: 10.1038/s41598-017-06100-7


Overcoming the tumor microenvironment: the role of nanohyperthermia

Author(s): Amanda K Silva, Alba Nicolas-Boluda, Laura Fouassier, Florence Gazeau

Published in: Nanomedicine, Issue 12/11, 2017, Page(s) 1213-1215, ISSN 1743-5889

DOI: 10.2217/nnm-2017-0096


Nanoparticle-based hyperthermia, a local treatment modulating the tumor extracellular matrix

Author(s): Jelena Kolosnjaj-Tabi, Iris Marangon, Alba Nicolas-Boluda, Amanda K.A. Silva, Florence Gazeau

Published in: Pharmacological Research, Issue 126, 2017, Page(s) 123-137, ISSN 1043-6618

DOI: 10.1016/j.phrs.2017.07.010